NCT00612599View on ClinicalTrials.gov

Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 50 to Biphasic Insulin Aspart 70 in Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL

Enrollment

75

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

June 30, 2004

Study Completion Date

June 30, 2004

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

biphasic insulin aspart

Trial Locations (1)

8000

Novo Nordisk Investigational Site, Århus C

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY

NCT00612599 - Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 50 to Biphasic Insulin Aspart 70 in Type 2 Diabetes | Biotech Hunter | Biotech Hunter